← Open Payments lookup

RACHAEL STILLWAGON: Open Payments

NPI 1437174208 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,586 in 122 payments from 19 companies in 2025. Trend: 2023 $949 · 2024 $1,245 · 2025 $2,586

Food & beverage: $2,463Education: $117Consulting: $6
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.15$547
GlaxoSmithKline, LLC.34$432
CSL Behring15$399
AstraZeneca Pharmaceuticals LP6$346
Novartis Pharmaceuticals Corporation12$188
Takeda Pharmaceuticals U.S.A., Inc.20$177
Amgen Inc.5$101
SANOFI-AVENTIS U.S. LLC1$100
Pharming Healthcare, Inc.2$61
GC Biopharma USA, Inc.3$49

Products named: DUPIXENT, NUCALA, Andembry, TEZSPIRE, FASENRA, CUVITRU, Hizentra, TRELEGY ELLIPTA.

Industry payments across AZ — which companies pay providers there.